Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ecstasy to Alleviate SEvere Chronic Neuropathic Pain (EASE Pain) Trial: A Randomized Controlled Pilot Trial

NCT07301632 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT07301632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07301632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ecstasy to Alleviate SEvere Chronic Neuropathic Pain (EASE Pain) Trial: A Randomized Controlled Pilot Trial
Lead sponsor
Unity Health Toronto
Phase
Phase 2
Overall status
Recruiting
Start date
January 30, 2026
Completion date
December 1, 2028
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic neuropathic pain